Granulation tissue formation is an example of new tissue development in an adult. Its rich vascular network has been thought to derive via angiogenic sprouting and extension of preexisting vessels from the surrounding tissue. The possibility that circulating cells of hematopoietic origin can differentiate into vascular endothelial cells (ECs) in areas of vascular remodeling has recently gained credibility. However, no quantitative data have placed the magnitude of this contribution into a physiological perspective. We have used hematopoietic chimeras to determine that 0.2% to 1.4% of ECs in vessels in control tissues derived from hematopoietic progenitors during the 4 months after irradiation and hematopoietic recovery. By contrast, 8.3% to 11.2% of ECs in vessels that developed in sponge-induced granulation tissue during 1 month derived from circulating hematopoietic progenitors. This recruitment of circulating progenitors to newly forming vessels would be difficult to observe in standard histological studies, but it is large enough to be encouraging for attempts to manipulate this contribution for therapeutic gain. W hen the endothelium is removed from a segment of large artery, the denuded region is reendothelialized via migration and proliferation of endothelial cells (ECs) from the adjacent intact endothelium. Occasionally, islands of ECs are observed, possibly representing colonization of the artery wall by circulating progenitors that had attached and proliferated. 1 However, these are essentially never observed after deendothelialization of the rat carotid artery, 2 the most thoroughly evaluated model of reendothelialization, and their origin is uncertain. New vessels can develop in adult tissue, eg, during granulation tissue formation. In this case, it is usually believed that with the exception of leukocytes, the cells that constitute this highly vascularized tissue, including fibroblasts, smooth muscle cells, and ECs, arrive via the proliferation and migration of these cell types from the adjacent tissue. Contribution by circulating cells would be very difficult to recognize, however, unless the two possible sources of ECs could be distinguished by informative markers.
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One source of circulating EC progenitors could be the hematopoietic system. During early development, hematopoiesis is closely associated with the formation of EC-lined spaces. Both angioblasts and embryonic hematopoietic progenitors express Flk-1, Tie-1, and CD34. Targeted disruption of the genes for Flk-1 3 and its ligand, vascular endothelial growth factor, 4 specifically disrupts both hematopoietic and EC function during development. This suggested the existence of a "hemangioblast," which can give rise to both hematopoietic stem cells and ECs, and a cell with this potential has been isolated from embryoid bodies. 5 Moreover, CD34ϩ stem cells from adult peripheral blood can reconstitute the hematopoietic system. 6 If some of these circulating cells have the developmental capacity of hemangioblasts, they might, under appropriate conditions, differentiate into ECs rather than hematopoietic cells.
Marked cells of hematopoietic origin injected intravenously into host mice or rabbits have been identified as ECs in the developing collateral vessels of ischemic tissues but not in vessels in unaffected tissue. 7, 8 This demonstrates that circulating cells can participate in the formation of endothelium, but no quantitative data have been reported to put this contribution into a physiological perspective. We undertook the present study to determine whether circulating hematopoietic-derived EC progenitors make a biologically significant contribution to new vessels compared with other sources of ECs.
Materials and Methods

Preparation of Marked Hematopoietic Chimeras
In E16 to E17 embryos, Ϸ50% of cells in the liver are involved in hematopoiesis. E16.5 wild-type embryos, homozygous for the genomic globin/pBR322 marker and expressing the Ly-5 b allele, were obtained by Caesarean section, and the livers were mechanically dissociated to provide cells for tail vein injection into C57BL6/J Ly-5 a recipient mice that had been irradiated 24 hours before transplantation to eliminate endogenous hematopoiesis. The chimeric mice were used 90 days after injection, at which time the globin/pBR322-marked cells had completely reconstituted the hematopoietic system. The Ly-5 marker was used together with markers for different hematopoietic lineages to confirm by flow cytometry that the host hematopoietic system had been eliminated and that donor hematopoietic cell types were present at levels within the normal range (J.R.C., W.E.K., P.J.M., E.W.R., D.F.B.-P., P. Lindahl, N.L. Lin, V. Broudy, B. Swolin, R. Ross, C. Betscholtz, unpublished data, 2000). The experimental protocol was approved by the University of Washington Committee for Animal Care and Use.
Evaluation of Hematopoietic Origin of ECs
We evaluated sections from the center of the sponge. The method for visualization of the integrated marker that identifies a cell of hematopoietic origin has been described elsewhere. 9, 10 Because the histological section does not always include the entire nucleus, false-negatives arise when the nuclear cross section does not include either of the two chromosomal globin marker loci. Because this is affected by nuclear shape and orientation, we used tissue from purebred (ie, nonchimeric) mice homozygous for the marker to determine the false-negative rate (6%) characteristic of ECs. All data have been corrected for this. Leukocytes associated with vessels were identified with the panleukocyte marker CD45 using rat monoclonal anti-mouse CD45 (clone 30-F11, Pharmingen), followed by biotinylated rabbit anti-rat IgG, then Vectastain elite ABC peroxidase (Vector), and visualized using diaminobenzidine. Laminin was stained using rabbit anti-mouse laminin (Collaborative Biomedical Products), followed by biotinylated goat anti-rabbit IgG Vectastain elite ABC peroxidase (Vector), and visualized using diaminobenzidine. ECs expressing von Willebrand factor (vWF) were identified by treating sections with proteinase K, then incubating with rabbit anti-human vWF (Dako), followed by biotinylated goat anti-rabbit IgG (Vector), then Vectastain ABC alkaline phosphatase (Vector), and visualized using Vector Red substrate (Vector). ECs expressing platelet-endothelial cell adhesion molecule (PECAM) (CD31) were identified by incubating with biotinylated rat anti-mouse CD31 (Pharmingen), followed by Vectastain ABC alkaline phosphatase (Vector), and visualized using Vector Red substrate (Vector). In all cases, the immunostained sections were counterstained with methyl green nuclear stain. To evaluate the extent of interobserver variation in identifying marked ECs, a series of micrographs of sections stained with each of the three reagent sets was separately scored by three of the coauthors. The values differed by 2% or less.
Results
To quantitate the contribution of circulating hematopoietic EC progenitors to new vessel formation, we prepared mouse hematopoietic chimeras in which cells derived from the hematopoietic system were marked by an integrated DNA marker detected as an unambiguous dark nuclear dot by nonisotopic in situ hybridization with a digoxigenin-labeled probe against the globin/pBR322 sequence. 9 Because detection does not involve gene expression, this avoids possible effects of differentiation on marker expression.
To initiate granulation tissue formation, we implanted four small sponges under the skin on the back. 10 By evaluating only tissue that developed within the sponge, we could specifically evaluate the contribution of marked cells to newly formed vessels. Four weeks later, we killed the mice and removed the sponges, along with samples of uninvolved skin, aorta, and brain. Tissues were fixed with methyl Carnoy's fixative, embedded, sectioned, and evaluated by nonisotopic in situ hybridization to visualize the marker of hematopoietic origin and by immunohistochemical staining to identify cell type. 9, 10 We identified ECs in vessels of all sizes using three sets of criteria, illustrated in the Figure: (1) flattened cells on the luminal side of the basement membrane (identified by immunostaining for laminin) that were negative for expression of the panleukocyte marker CD45 (panel A); (2) flattened vWF-positive cells surrounding a lumen (panel C); and (3) PECAM-positive cells surrounding a lumen (panel E). The three methods for identifying ECs detected somewhat different numbers of ECs per optical field, but the percentage of these that were positive for the globin marker of hematopoietic origin were very similar: 8.3% to 11.2% (panels B, D, and F). By contrast, the percentage of marked ECs in normal tissues was only 0.2% to 1.4%. These results demonstrate that circulating cells of hematopoietic origin make a significant contribution to the endothelium of new vessels, and that these hematopoietic-derived ECs were not different from ECs of host tissue origin in expression of any of the EC markers evaluated.
Discussion
The recruitment of circulating hematopoietic-derived EC progenitors to newly forming vessels is small enough in magnitude to explain how this source of ECs might have been overlooked in histological studies but large enough to be encouraging for attempts to manipulate this contribution for therapeutic gain. Isner's group has demonstrated that the number of circulating progenitors can be augmented by ischemia and granulocyte/macrophage colony-stimulating factor. 11 This augmentation will clearly be important for maximizing the contribution of circulating progenitors to new vessel formation. In addition, this pathway must also be regulated at the level of the destination tissue, because the contribution of hematopoietic progenitors appears to be greatly augmented at sites of new vessel formation. Consistent with earlier studies, 7, 8 we found that marked hematopoietic progenitors did not make significant contributions to the endothelium of blood vessels in stable adult tissue, even during 4 months, 4-fold longer than the time during which the granulation tissue formed.
In future studies, it will be important to determine the mechanisms that specifically recruit progenitors to newly forming vessels. Are specific adhesion molecules upregulated that help localize the circulating progenitors, or is the enhancement due to an increased propensity of progenitors to differentiate into ECs in new, but not mature, vessels? Do the progenitors arrive in the tissue and then coalesce into vessels as in vasculogenesis, or are they recruited by attachment to, and integration into, the growing tips or shafts of existing vessels extending via angiogenic mechanisms?
